A recent preclinical study described palmitoyl-protein thioesterase 1 (PPT1), a lysosomal enzyme whose expression is correlated with a poor prognosis in cancer patients, as the point of attack for the autophagy modulating and antineoplastic activity of CQ and its derivative DC661 [132]. Here, PPT1 is linked to cancer.